| abstract |
A pharmaceutical combination comprising 2-8 mg of 5- [4- / 2- (N-methyl-N- (2-pyridyl) amino) ethoxy / benzyl] thiazolidine-2,4-dione (Compound I) or a tautomeric form thereof, and or a pharmaceutically acceptable derivative thereof and a sulfonylurea. The sulfonylurea is also glibenclamide, glipizide, gliclazide, glimepiride, tolazamide or tolbutamide. The solution is also the use of this combination in a pharmaceutical composition for the treatment of diabetes mellitus and / or a condition associated with diabetes mellitus. |